• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子信号转导抑制因子-1 可改善糖尿病肾病中 MCP-1 的表达。

Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy.

机构信息

Department of Pathology, Hebei Medical University, Shijiazhuang, PR China.

出版信息

Am J Nephrol. 2010;31(5):380-8. doi: 10.1159/000286559. Epub 2010 Mar 19.

DOI:10.1159/000286559
PMID:20299783
Abstract

BACKGROUND

Janus kinase (JAK)/signal transducers and activators of transcription (STAT) contribute to diabetic nephropathy. Suppressor of cytokine signaling-1 (SOCS-1) is one of the negative feedback regulators of JAK/STAT signaling. This study investigated the effect of SOCS-1 on the JAK/STAT pathway and MCP-1 expression in diabetic nephropathy.

METHODS

Streptozotocin-induced diabetic mice received pEF-FLAG-I/mSOCS-1 plasmid or pEF-FLAG-I vector for 4 weeks and were compared with age-matched nondiabetic mice. Functional and pathologic markers, expression of monocyte chemoattractant protein-1 (MCP-1) and TGF-beta1 and phosphorylation of STAT1 and STAT3 were assessed. The effect of SOCS-1 on the expression of MCP-1 in mesangial cells under high glucose conditions was also examined.

RESULTS

Urine albumin excretion and renal hypertrophy were alleviated in diabetic mice by overexpression of SOCS-1. The expression of TGF-beta1 and MCP-1 and the activation of STAT1 and STAT3 were significantly inhibited in diabetic kidney by gene delivery of SOCS-1. In cultured mesangial cells, overexpression of SOCS-1 markedly suppressed high glucose-induced MCP-1 expression.

CONCLUSIONS

This study suggests that SOCS-1 may attenuate renal damage by ameliorating MCP-1 expression and regulation of the phosphorylation of JAK/STAT in diabetic mice.

摘要

背景

Janus 激酶(JAK)/信号转导和转录激活因子(STAT)参与糖尿病肾病的发生。细胞因子信号转导抑制因子-1(SOCS-1)是 JAK/STAT 信号通路的负反馈调节因子之一。本研究旨在探讨 SOCS-1 对糖尿病肾病中 JAK/STAT 通路和单核细胞趋化蛋白-1(MCP-1)表达的影响。

方法

链脲佐菌素诱导的糖尿病小鼠接受 pEF-FLAG-I/mSOCS-1 质粒或 pEF-FLAG-I 载体治疗 4 周,并与年龄匹配的非糖尿病小鼠进行比较。评估功能性和病理标志物、单核细胞趋化蛋白-1(MCP-1)和转化生长因子-β1(TGF-β1)的表达以及 STAT1 和 STAT3 的磷酸化。还观察了 SOCS-1 对高糖条件下系膜细胞 MCP-1 表达的影响。

结果

SOCS-1 的过表达减轻了糖尿病小鼠的尿白蛋白排泄和肾脏肥大。SOCS-1 的基因转染显著抑制了糖尿病肾脏中 TGF-β1 和 MCP-1 的表达以及 STAT1 和 STAT3 的激活。在培养的系膜细胞中,SOCS-1 的过表达显著抑制了高糖诱导的 MCP-1 表达。

结论

本研究表明,SOCS-1 可能通过改善 MCP-1 表达和调节糖尿病小鼠 JAK/STAT 的磷酸化来减轻肾脏损伤。

相似文献

1
Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy.细胞因子信号转导抑制因子-1 可改善糖尿病肾病中 MCP-1 的表达。
Am J Nephrol. 2010;31(5):380-8. doi: 10.1159/000286559. Epub 2010 Mar 19.
2
Suppressor of cytokine signaling-1 reduces high glucose-induced TGF-beta1 and fibronectin synthesis in human mesangial cells.细胞因子信号转导抑制因子1减少高糖诱导的人系膜细胞中转化生长因子-β1和纤连蛋白的合成。
FEBS Lett. 2008 Oct 15;582(23-24):3484-8. doi: 10.1016/j.febslet.2008.09.014. Epub 2008 Sep 16.
3
Suppressors of cytokine signaling abrogate diabetic nephropathy.细胞因子信号抑制剂可阻断糖尿病肾病。
J Am Soc Nephrol. 2010 May;21(5):763-72. doi: 10.1681/ASN.2009060625. Epub 2010 Feb 25.
4
Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.细胞因子信号转导抑制因子在动脉粥样硬化过程中调节JAK/STAT介导的细胞反应。
Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):525-31. doi: 10.1161/ATVBAHA.108.173781. Epub 2009 Jan 22.
5
Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy.细胞因子信号转导抑制因子(SOCS)2 可减轻糖尿病肾病大鼠的肾脏病变。
Acta Histochem. 2014 Jun;116(5):981-8. doi: 10.1016/j.acthis.2014.04.002. Epub 2014 May 5.
6
Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.细胞因子信号转导抑制因子 1 衍生肽抑制 Janus 激酶/信号转导和转录激活因子通路,改善糖尿病小鼠的炎症和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1953-60. doi: 10.1161/ATVBAHA.114.304144. Epub 2014 Jul 10.
7
Danzhi Jiangtang Capsule ameliorates kidney injury via inhibition of the JAK-STAT signaling pathway and increased antioxidant capacity in STZ-induced diabetic nephropathy rats.丹蛭降糖胶囊通过抑制 JAK-STAT 信号通路和提高糖尿病肾病大鼠的抗氧化能力来改善肾脏损伤。
Biosci Trends. 2019 Jan 22;12(6):595-604. doi: 10.5582/bst.2018.01255. Epub 2018 Dec 28.
8
Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy.JAK/STAT/SOCS信号通路参与糖肾方治疗糖尿病肾病机制的证据。
Planta Med. 2014 Jun;80(8-9):614-21. doi: 10.1055/s-0034-1368454. Epub 2014 May 22.
9
STAT1 regulates interferon-γ-induced angiotensinogen and MCP-1 expression in a bidirectional manner in primary cultured mesangial cells.STAT1 以双向方式调节原代培养系膜细胞中干扰素-γ诱导的血管紧张素原和单核细胞趋化蛋白-1 的表达。
J Renin Angiotensin Aldosterone Syst. 2020 Jul-Sep;21(3):1470320320946527. doi: 10.1177/1470320320946527.
10
The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.JAK抑制剂JAB/SOCS-1可选择性抑制细胞因子诱导的JAK-STAT激活,但对v-Src诱导的JAK-STAT激活无抑制作用。
Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829.

引用本文的文献

1
Inflammation in glomerular diseases.肾小球疾病中的炎症
Front Immunol. 2025 Mar 4;16:1526285. doi: 10.3389/fimmu.2025.1526285. eCollection 2025.
2
A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease.miR-155与SOCS1之间的相互调节环影响肾脏炎症和糖尿病肾病。
Mol Ther Nucleic Acids. 2023 Sep 27;34:102041. doi: 10.1016/j.omtn.2023.102041. eCollection 2023 Dec 12.
3
AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway.
AG1024,一种胰岛素样生长因子-1受体抑制剂,通过细胞因子信号转导抑制蛋白/Janus激酶2/信号转导和转录激活因子途径改善糖尿病肾病大鼠的肾损伤。
Open Med (Wars). 2023 Apr 6;18(1):20230683. doi: 10.1515/med-2023-0683. eCollection 2023.
4
Advances in understanding the innate immune-associated diabetic kidney disease.对先天性免疫相关糖尿病肾病认识的进展
FASEB J. 2021 Feb;35(2):e21367. doi: 10.1096/fj.202002334R.
5
STAT1 regulates interferon-γ-induced angiotensinogen and MCP-1 expression in a bidirectional manner in primary cultured mesangial cells.STAT1 以双向方式调节原代培养系膜细胞中干扰素-γ诱导的血管紧张素原和单核细胞趋化蛋白-1 的表达。
J Renin Angiotensin Aldosterone Syst. 2020 Jul-Sep;21(3):1470320320946527. doi: 10.1177/1470320320946527.
6
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.靶向糖尿病肾病炎症的致病途径和治疗方法。
Int J Mol Sci. 2020 May 27;21(11):3798. doi: 10.3390/ijms21113798.
7
STAT signaling in polycystic kidney disease.STAT 信号通路在多囊肾病中的作用。
Cell Signal. 2020 Aug;72:109639. doi: 10.1016/j.cellsig.2020.109639. Epub 2020 Apr 20.
8
Suppressor of Cytokine Signaling-1/STAT1 Regulates Renal Inflammation in Mesangial Proliferative Glomerulonephritis Models.细胞因子信号转导抑制因子-1/STAT1 调控系膜增生性肾小球肾炎模型中的肾脏炎症。
Front Immunol. 2018 Aug 30;9:1982. doi: 10.3389/fimmu.2018.01982. eCollection 2018.
9
DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial Cells.DJC抑制晚期糖基化终产物诱导的系膜细胞中JAK-STAT信号通路和活性氧生成。
Evid Based Complement Alternat Med. 2017;2017:2942830. doi: 10.1155/2017/2942830. Epub 2017 May 29.
10
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.细胞因子信号传导抑制因子-1拟肽可限制糖尿病肾病的进展。
J Am Soc Nephrol. 2017 Feb;28(2):575-585. doi: 10.1681/ASN.2016020237. Epub 2016 Sep 8.